Krystal Biotech Ownership | Who Owns Krystal Biotech?
Krystal Biotech Ownership Summary
Krystal Biotech is owned by 61.43% institutional investors, 12.48% insiders, and 26.09% retail investors. Fmr is the largest institutional shareholder, holding 15.02% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.50% of its assets in Krystal Biotech shares.
KRYS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Krystal Biotech | 61.43% | 12.48% | 26.09% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.31M | 15.02% | $675.83M |
| Blackrock funding, inc. /de | 4.03M | 14.05% | $631.95M |
| Blackrock | 3.95M | 13.95% | $724.98M |
| Vanguard group | 2.88M | 10.02% | $450.94M |
| Avoro capital advisors | 2.63M | 9.15% | $411.83M |
| State street | 1.33M | 4.71% | $244.77M |
| Frazier life sciences management | 988.46K | 3.49% | $181.52M |
| Capital world investors | 879.20K | 3.06% | $137.74M |
| Redmile group | 753.17K | 2.62% | $117.99M |
| Geode capital management | 591.60K | 2.06% | $92.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Frazier life sciences management | 988.46K | 8.49% | $181.52M |
| Redmile group | 753.17K | 8.22% | $117.99M |
| S squared | 95.22K | 6.20% | $14.92M |
| Avoro capital advisors | 2.63M | 5.83% | $411.83M |
| Soleus capital management | 358.38K | 3.53% | $56.14M |
| Decheng capital | 76.77K | 2.58% | $12.03M |
| Evolutionary tree capital management | 10.70K | 1.71% | $1.68M |
| Hood river capital management | 512.73K | 1.19% | $80.32M |
| Braidwell lp | 200.50K | 0.93% | $31.41M |
| Healthinvest partners ab | 9.20K | 0.70% | $1.47M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.95M | 0.02% | 2.14M |
| State street | 1.33M | 0.01% | 388.33K |
| Norges bank | 219.53K | 0.00% | 219.53K |
| Soleus capital management | 358.38K | 3.53% | 141.40K |
| Raymond james financial | 102.06K | 0.01% | 102.06K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | - | - | -375.00K |
| Jennison associates | 303.52K | 0.03% | -106.54K |
| Invesco | 275.19K | 0.01% | -90.36K |
| Integral health asset management | - | - | -85.00K |
| Allspring global investments | 29.78K | 0.01% | -81.93K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 219.53K | 0.00% | 219.53K | $34.39M |
| Raymond james financial | 102.06K | 0.01% | 102.06K | $15.99M |
| Eagle asset management | 76.26K | 0.07% | 76.26K | $13.90M |
| Caption management | 22.34K | 0.03% | 22.34K | $3.50M |
| Hrt financial lp | 22.01K | 0.02% | 22.01K | $3.45M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Mendota financial group | -2.00 |
| Bokf, na | -2.00 |
| Riverview trust | -3.00 |
| Capital performance advisors llp | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 175 | -41.28% | 17,639,222 | -37.00% | 61 | 0.65% | 85 | -45.51% | 63 | -31.52% |
| Sep 30, 2024 | 297 | 16.47% | 27,997,874 | -1.68% | 97 | 0.98% | 156 | - | 92 | 31.43% |
| Jun 30, 2024 | 253 | - | 28,459,261 | 12.90% | 100 | 1.17% | 155 | 18.32% | 69 | -19.77% |
| Mar 31, 2024 | 253 | 24.63% | 25,206,890 | 3.33% | 92 | 1.23% | 131 | 31.00% | 86 | 26.47% |
| Dec 31, 2023 | 203 | 2.01% | 24,393,819 | 2.62% | 86 | 1.09% | 100 | -7.41% | 68 | 23.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 1.88M | 6.50% | - |
| iShares Core S&P Small-Cap ETF | 1.57M | 5.42% | 896.00 |
| Fidelity Growth Compy Commingled Pl S | 945.47K | 3.27% | 6.61K |
| Fidelity Growth Compy Commingled Pl O | 915.43K | 3.19% | - |
| Vanguard US Total Market Shares ETF | 824.72K | 2.86% | 704.00 |
| Vanguard Total Stock Mkt Idx Inv | 821.67K | 2.85% | 585.00 |
| American Funds SMALLCAP World A | 811.71K | 2.82% | - |
| Fidelity Growth Company Fund | 693.23K | 2.40% | 2.30K |
| Vanguard Small Cap Index | 660.91K | 2.29% | 546.00 |
| iShares Russell 2000 ETF | 651.53K | 2.25% | -5.67K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | $1.21M |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | $1.94M |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | $874.12K |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | $193.41K |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | $225.54K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 21 |
| 2024 Q4 | - | 34 |
| 2024 Q3 | - | 30 |
| 2024 Q2 | - | 35 |
| 2024 Q1 | - | 53 |
KRYS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools